Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study - Oakes, Tina Marie Myers; Skljarevski, Vladimir; Zhang, Qi; Kielbasa, William; Hodsdon, Michael E; Detke, Holland C; Camporeale, Angelo; Saper, Joel R (Cephalalgia, 2018)
Keywords: Adolescent; Adult; Aged; Antibodies, Monoclonal - therapeutic use; Calcitonin Gene-Related Peptide - antagonists & inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders - drug therapy; Treatment Outcome; Young Adult; calcitonin gene-related peptide; LY2951742; Galcanezumab; episodic migraine; safety; phase 2b study